Indications
     Chronic hepatitis, cirrhosis of the liver, fatty liver of various etiologies, toxic liver damage, alcoholic hepatitis, liver dysfunction in other somatic diseases.
     Toxicosis of pregnancy.
     Prevention of recurrence of gallstone formation.
     Psoriasis (as an adjuvant therapy).
     Radiation syndrome.

Use during pregnancy and breastfeeding
Pregnancy
The use of Essentiale® forte N during pregnancy is not recommended without medical supervision. There is not enough research.

Breastfeeding period
To date, no risks have been identified when using products containing soy during breastfeeding. However, due to the lack of relevant studies involving women during breastfeeding, the use of Essentiale® forte N during breastfeeding is not recommended.

Contraindications
     Hypersensitivity to phosphatidylcholine, soy, soybeans or other ingredients of the drug.
     Children under 12 years of age (lack of sufficient evidence base).

Side effects
Essentiale® forte N is usually well tolerated by patients.
According to the World Health Organization (WHO), side effects are classified according to their frequency as follows: very common (≥ 1/10), common (≥1/100, < 1/10), uncommon (≥1/1000, < 1/100), rare (≥1/10000, <1/1000) and very rare (<1/10000); frequency unknown (frequency cannot be determined from available data).
From the gastrointestinal tract
Not known: stomach discomfort, soft stools, or diarrhea.
From the skin and subcutaneous tissues
Frequency unknown: allergic reactions (rash, exanthema, urticaria), itching.

Storage conditions
Store at a temperature not exceeding 21 °C. Keep out of the reach of children.

Best before date
For capsules packed in a blister made of PVC and aluminum foil - 3 years.